• Background
logo
  • Home
  • Who we are
    Who we are
    • Overview
    • Fact Sheet
    • Chairman's Profile
    • Board of Directors
    • Team Wockhardt
    Faclities
    • Manufacturing
    • Contract Manufacturing
    • Virtual Tour
    Global Presence
    • Our Footprints
    • Other websites
    Community Care
    • Wockhardt Foundation
    • Wockhardt HIV/AIDS Care
  • We touch lives
    R & D
    • Overview
    • Generics
    • New Drug Discovery
    Biotechnology
    • Overview
    • Biopharmaceuticals
    • Biotechnology Park
    • Gallery
    Corporate Regulatory
    • Marketing & Regulatory Infrastructure
  • Products
    • Search Products
  • Partnerships
    • Collaborations / Partnerships
  • People
    • Life at Wockhardt
    • Frequently Asked Questions
    • Focus on Development
    • Meet our People
    • Career Openings
  • Investors
    • Financials at a glance
    • Annual Reports
    • Quarterly Reports
    • Shareholding Pattern
    • Chairman's letter to Shareowners
    • Chairman's AGM Speeches
    • Code of Conduct
    • Financial Press Releases
    • Stock Quotes
    • Investor Communication
    • Investor Contact
    • Investor Meet
  • Media
    • Press Releases
    • Media Kit
    • Videos
    • Media Contact
  • Get in touch
    • Corporate Office
    • International Offices
    • Research Centres
    • Manufacturing Plants
  • Home
  • >
  • Media
  • >
  • Press Releases

Press Releases

Press releases
Archives
123Prev
FINANCIAL RESULTS FY 2012 – 13 Q3 (OCT – DEC 2012)
14 February, 2013
Wockhardt receives the 'Best Enterprise' award from the Europe Business Assembly
10 January, 2013
Wockhardt launches generic version of anti-convulsant drug Lamictal XR
08 January, 2013
FINANCIAL RESULTS FY 2012-13 Q2 (JUL- SEP 2012)
14 November, 2012
Wockhardt launches generic version of anti-­ulcer drug Prevacid®
17 September, 2012
Wockhardt launches generic version of anti-depressant drug Wellbutrin® SR
03 September, 2012
Wockhardt receives US FDA approval for generic version of Parkinsonism drug Requip XL®
28 August, 2012
Wockhardt receives tentative US FDA approval for generic version of anti-psychotic drug Geodon®
22 August, 2012
Wockhardt to launch generic version of anti-hypertensive drug Plendil®
21 August, 2012
Wockhardt receives US FDA approval for generic version of Parkinson’s drug Comtan®
20 August, 2012
123Prev
© 2012 wockhardt. All rights reserved.Sitemap | Terms & conditions | Disclaimer | XHTML1.0 | CSS
WOCK-STOCK Stock WatchMarket Tracker